CC
IMUC

Callan Capital’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Callan Capital’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,598
Closed -$143K – 79
2015
Q2 		$143K Sell
7,598
-500
-6% -$9.62K 0.03% 65
2015
Q1 		$157K Sell
8,098
-1,750
-18% -$43.9K 0.03% 65
2014
Q4 		$288K Hold
9,848
– – 0.07% 64
2014
Q3 		$351K Hold
9,848
– – 0.1% 54
2014
Q2 		$441K Buy
9,848
+8,098
+463% +$391K 0.12% 50
2014
Q1 		$85K Hold
1,750
– – 0.03% 49
2013
Q4 		$65K Hold
1,750
– – 0.02% 46
2013
Q3 		$180K Sell
1,750
-523
-23% -$57.4K 0.09% 38
2013
Q2 		$176K Buy
+2,273
New +$218K 0.1% 32

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return